Phase Genomics

Phase Genomics is a private biotechnology company that has commercialized a proprietary 'proximity ligation' (Hi-C) technology platform to enable ultra-long-range genome sequencing and analysis. Its three main product platforms—CytoTerra for cytogenetics, ProxiMeta for metagenome deconvolution, and Proximo for genome scaffolding—serve diverse markets including oncology, microbiology, and agricultural genomics. The company is in a revenue-generating stage, selling kits, software, and services to academic, biopharmaceutical, and agricultural research institutions globally.

Proprietary proximity ligation (Hi-C) technology for ultra-long-range genome sequencing and analysis, enabling chromosome-scale assembly, metagenome deconvolution, and high-resolution cytogenetics.

Operates in a competitive tools segment against established long-read sequencing companies (PacBio, Oxford Nanopore) and large NGS players (Illumina) who are integrating long-range capabilities. Also competes with specialized bioinformatics software providers. Differentiation lies in the unique spatial chromatin capture approach (Hi-C) for specific applications like metagenome binning and cytogenetics.